Retained Earnings (Accumulated Deficit) of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2024 was $699,224, a 48% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $699,224 -$226,258 -48% 31 Dec 2024 20-F 13 Jun 2025 2024 FY
Q4 2023 $472,966 +$751,609 +61% 31 Dec 2023 20-F/A 23 Sep 2025 2023 FY
Q3 2023 $477,490 30 Sep 2023 6-K 13 Nov 2023 2023 Q3
Q4 2022 $1,224,575 -$720,093 -143% 31 Dec 2022 20-F/A 23 Sep 2025 2023 FY
Q4 2021 $504,482 -$491,006 -3644% 31 Dec 2021 20-F 15 May 2023 2022 FY
Q4 2020 $13,476 31 Dec 2020 20-F 15 May 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.